Evidence map›Paper›PMID 21790653›Full record

ReviewInternational journal of andrology2011

Human spermatogonial stem cells: a possible origin for spermatocytic seminoma.

R Waheeb, M-C Hofmann

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of andrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Stem cell origin of testicular seminoma.Clinical genitourinary cancer · 2013
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Spermatocytic tumor: A rare case report.World journal of clinical cases · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Arrestin-independent constitutive endocytosis of GPR125/ADGRA3.Annals of the New York Academy of Sciences · 2019
    Article
  17. A case of spermatocytic seminoma in young individual.Medical journal, Armed Forces India · 2018
    Article
  18. The GDNF Family: A Role in Cancer?Neoplasia (New York, N.Y.) · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

R WaheebDepartment of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
M-C Hofmann
University of Illinois Urbana-Champaign · US

Funding

Isolation and Characterization of Testis Stem CellsR01HD044543 · NICHD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HOFMANN, MARIE-CLAUDE CATHERINE · 2005 to 2009
$1.4M
CDA: Isolation and Characterization Testis Stem Cells; Influence of GDNFK02HD054607 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HOFMANN, MARIE-CLAUDE CATHERINE · 2007 to 2011
$638k
NICHD NIH HHS HD054607NICHD NIH HHS K02 HD054607NICHD NIH HHS R01 HD044543
6 · The paper itself

Abstract

In mammals, spermatogenesis is maintained throughout life by a small subpopulation of type A spermatogonia called spermatogonial stem cells (SSCs). In rodents, SSCs, or Asingle spermatogonia, form the self-renewing population. SSCs can also divide into Apaired (Apr) spermatogonia that are predestined to differentiate. Apaired spermatogonia produce chains of Aaligned (Aal) spermatogonia that divide to form A1 to A4, then type B spermatogonia. Type B spermatogonia will divide into primary spermatocytes that undergo meiosis. In human, there are only two different types of A spermatogonia, the Adark and Apale spermatogonia. The Adark spermatogonia are considered reserve stem cells, whereas the Apale spermatogonia are the self-renewing stem cells. There is only one generation of type B spermatogonia before differentiation into spermatocytes, which makes human spermatogenesis less efficient than in rodents. Although the biology of human SSCs is not well known, a panel of phenotypic markers has recently emerged that is remarkably similar to the list of markers expressed in mice. One such marker, the orphan receptor GPR125, is a plasma membrane protein that can be used to isolate human SSCs. Human SSCs proliferate in culture in response to growth factors such as GDNF, which is essential for SSC self-renewal in mice and triggers the same signalling pathways in both species. Therefore, despite differences in the spermatogonial differentiation scheme, both species use the same genes and proteins to maintain the pool of self-renewing SSCs within their niche. Spermatocytic seminomas are mainly found in the testes of older men, and they rarely metastasize. It is believed that these tumours originate from a post-natal germ cell. Because these lesions can express markers specific for meiotic prophase, they might originate from a primary spermatocyte. However, morphological appearance and overall immunohistochemical profile of these tumours indicate that the cell of origin could also be a spermatogonial stem cell.

Indexed as

AnimalsBiomarkers, TumorCell DifferentiationHumansMaleSeminomaSignal TransductionSpermatogenesisSpermatogoniaStem CellsBiomarkers, Tumor

Identifiers

PMID21790653
PMCPMC3146023
OpenAlexW1916200931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.